LAWRENCE DAVID 4
4 · ACORDA THERAPEUTICS INC · Filed Jun 13, 2018
Insider Transaction Report
Form 4
LAWRENCE DAVID
Chief Financial Officer
Transactions
- Sale
Common Stock
2018-06-12$31.65/sh−3,131$99,099→ 4,993 total - Sale
Common Stock
2018-06-12$32.68/sh−300$9,805→ 4,693 total
Footnotes (3)
- [F1]Sales pursuant to a 10b5-1 plan.
- [F2]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $31.40 to $32.10 per share. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- [F3]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $32.60 to $32.80 per share. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.